Blog — brain health

  Neurotransmitters play a crucial role in our everyday lives, although many of us may not be aware of their significance. These chemical messengers are responsible for relaying information between nerve cells in the nervous system, allowing our bodies to function properly. When neurotransmitter levels are imbalanced, it can lead to a range of neurological and psychological symptoms, affecting our overall well-being.Recent studies have shown that approximately 86% of Americans have suboptimal neurotransmitter levels. This alarming statistic highlights the importance of understanding neurotransmitter balance and the potential impact it can have on our health. Thankfully, there are tests available that...

Neurotransmitters are chemical messengers in the brain that play a crucial role in regulating our mood, emotions, behaviour, and overall mental health. Imbalances in neurotransmitters have been linked to a range of psychiatric and neurological disorders, including depression, anxiety, ADHD, Parkinson's disease, and Alzheimer's disease. A neurotransmitter test is a non-invasive diagnostic tool that can help identify these imbalances and provide valuable insights into an individual's brain chemistry. In this blog, we will explore the benefits of neurotransmitter testing and how it can help improve our mental health and well-being. Accurate Diagnosis: A neurotransmitter test can accurately diagnose the underlying...

By Dr Beth Baldwing In part 1 of this blog post, we discussed the use of inositol for insulin resistance and related conditions. However, in the late 1990s and early 2000s researchers were largely focused on the effects of inositol on mood. A link between insulin resistance and depression has been established since, and may eventually provide one possible mechanism of action. (1) ​A 2014 meta-analysis suggested that inositol may be beneficial in depression, particularly premenstrual dysphoric disorder. (2) Numerous smaller studies found inositol to be effective for a spectrum of disorders that usually respond to selective serotonin reuptake inhibitors (3), including panic (4) and obsessive-compulsive...

By Dr.David Zava, ZRT Laboratory In 2002 several large-scale clinical studies were published on the risks of breast cancer in postmenopausal women using conventional FDA-approved hormone therapy. These were the Women’s Health Initiative (WHI) and Million Women’s studies of women using FDA-approved estrogens and progestogens in the United States and Great Britain, respectively [1,2]. Both studies came to the same conclusion – that estrogen therapy, mostly in the form of oral conjugated equine estrogens, by itself did not significantly increase the risk of breast cancer and, to the surprise of many, was associated with a lower risk. However, when estrogen was...